SLC29A1 and non-small cell lung carcinoma: When pre-treated with ENT1 inhibitor NBMPR (Figure 1), the pemetrexed-induced “flare” in DNA salvage pathway was markedly diminished in both the H460 and H1299 NSCLC cell lines.